Cite
HARVARD Citation
Kraynyak, K. et al. (2022). SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. Journal of infectious diseases. pp. 1923-1932. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kraynyak, K. et al. (2022). SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. Journal of infectious diseases. pp. 1923-1932. [Online].